Patent · US Active

Device and method for determining analyte levels

US7711402B2 · kind B2 · utility

768Cited by

373References

38Claims

0Family size

Assignee

Dexcom, Inc. · US

Inventors

Mark C. Shults · Madison, US
Stuart J. Updike · Madison, US
Rathbun K. Rhodes · Madison, US

Key dates

Filing date	Dec 22, 2004
Grant date	May 4, 2010
Priority date	—
Expiry date	Mar 15, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q1/006
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.